RGEN Earnings Prediction
The chart below shows how RGEN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, RGEN sees a -0.55% change in stock price 10 days leading up to the earnings, and a +4.47% change 10 days following the report. On the earnings day itself, the stock moves by +4.90%. This data can give you a slight idea of what to expect for the next quarter's release.
RGEN Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
167.55M
7.58%
8.18%
Gross Margin
23.18%
-52.05%
-54.54%
Operating Margin
9.73%
49.00%
-452.54%
Net Margin
-20.21%
23.46%
4711.90%
EPS
-0.60
-30.43%
5900.00%
No Data Available
RGEN Earnings Analysis
Repligen Corp Corporation (RGEN.O) Earnings Conference Call
Positive
Earnings Beat Expectations: Repligen Corporation beats earnings expectations with reported EPS of $0.44, exceeding expectations of $0.41.
Quarterly and Annual Revenue: Achieved fourth quarter revenue of $167.5 million and full year revenue of $634.4 million, aligning with the midpoint of guidance despite currency headwinds.
CDMO and Equipment Surge: Strong performance in the CDMO and equipment sectors, with CDMO sales and orders up high double digits sequentially and equipment sales and orders up more than 30% sequentially.
Filtration and Analytics Success: Filtration and Analytics franchises performed excellently, with Filtration revenues up 30% year-over-year in Q4 and Analytics achieving record sales and orders since the acquisition of C Tech in 2019.
Future Product Launches: New product launches in 2024, including the KrosFlow RS 10 RPM system and AVIPure double-stranded RNA resin, are expected to drive future growth.
Gross Margin Improvement: Adjusted gross margin improved to 50.7% in Q4, with a full year adjusted gross margin increase of 140 basis points, reflecting strong productivity and pricing discipline.
Strong Fourth Quarter Orders: Fourth quarter orders were exceptionally strong, up 11% sequentially and year-over-year, marking the highest order intake since Q2 2022.
Revenue Growth Guidance: 2025 guidance projects revenue growth of 8% to 12% on a reported basis, with a focus on maintaining above-market growth and expanding margins.
Negative
Sluggish Revenue Recovery: Revenue growth for 2024 was only 3% on a non-COVID basis, indicating a sluggish recovery in the market.
Exchange Rate Impact: The company faced a $3.5 million exchange rate headwind in the fourth quarter, which impacted overall revenue performance.
Flat Revenue Concerns: Despite a strong fourth quarter, the overall revenue for 2024 was flat compared to the previous year, raising concerns about long-term growth.
Operating Income Decline: Operating income for the full year decreased by approximately $6 million compared to 2023, reflecting challenges in maintaining profitability.
Decline in Adjusted Net Income: Adjusted net income for the full year was down about $4 million or 5% from 2023, indicating pressure on the bottom line.
Restructuring and Inventory Charges: The company incurred approximately $45 million in nonrecurring restructuring and inventory-related charges in the fourth quarter, which could signal operational inefficiencies.
China Sales Outlook: China was identified as a significant headwind, with sales expected to remain flat in 2025, which could limit growth potential in that region.
Operating Expenses Increase: Operating expenses increased by approximately $16 million compared to last year, primarily due to performance-based bonuses, which could affect future profitability.
Tax Rate Increase Impact: The adjusted effective tax rate is expected to increase to 22% to 23%, which could further pressure net income.
Inflation Impact on Margins: The company anticipates inflation and investments in operating expenses to be key headwinds in 2025, which may hinder margin expansion.
RGEN FAQs
How does RGEN typically perform around its earnings report dates?
Is Repligen Corp (RGEN) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
RGEN Earning Call Sentiment
Repligen Corporation (NASDAQ:RGEN) Q4 2024 Earnings Call Transcript
RGEN.O
3.72%Positive
The earnings call reveals several positive indicators: record high revenue for new modalities, strong CDMO growth, and a significant cash flow increase. Despite a slight EPS decline, guidance for 2025 suggests a return to growth, supported by strategic initiatives like the Tantti acquisition and training center opening. The Q&A highlighted strong order trends and confidence in future growth. While there were some management ambiguities, the overall sentiment is optimistic, suggesting a stock price increase of 2% to 8% over the next two weeks.
